Bronchiolitis Clinical Practice Guidelines Vary in Quality

This article originally appeared here.
Share this content:
Bronchiolitis Clinical Practice Guidelines Vary in Quality
Bronchiolitis Clinical Practice Guidelines Vary in Quality

MONDAY, Sept. 14, 2015 (HealthDay News) -- Clinical practice guidelines (CPGs) on acute viral bronchiolitis vary in quality, with the highest scoring domains being "scope and purpose" and "clarity of presentation," according to a study published online Sept. 8 in the Journal of Evaluation in Clinical Practice.

Carlos E. Rodriguez-Martinez, M.D., from the Universidad Nacional de Colombia in Bogota, and colleagues performed a systematic search of CPGs on acute viral bronchiolitis published from 2000 to 2014. The quality of CPGs was assessed by three independent appraisers. For each of six domains, a standardized score was calculated and the CPGs were rated as recommended, recommended with modifications, or not recommended.

The researchers selected six CPGs published between 2000 and 2014 from a total of 111 citations. Considerable agreement was found among reviewers. The domains for "scope and purpose" scored highest, with a mean value of 92.1 percent, while "clarity of presentation" scored 83.3 percent. The lowest scoring domains were "applicability" and "stakeholder involvement" (44.3 and 66.7 percent, respectively). Two CPGs were recommended for use in clinical practice and three were recommended with modifications.

"Available bronchiolitis CPGs vary in quality, and the findings of the present study are useful for identifying aspects or domains where there is room for improvement in future CPGs," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »